相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mechanism of CFTR correction by type I folding correctors
Karol Fiedorczuk et al.
CELL (2022)
Distinct proteostasis states drive pharmacologic chaperone susceptibility for cystic fibrosis transmembrane conductance regulator misfolding mutants
Eli Fritz McDonald et al.
MOLECULAR BIOLOGY OF THE CELL (2022)
Structural Comparative Modeling of Multi-Domain F508del CFTR
Eli Fritz McDonald et al.
BIOMOLECULES (2022)
Molecular basis for variations in the sensitivity of pathogenic rhodopsin variants to 9-cis-retinal
Francis J. Roushar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2022)
Molecular structures reveal synergistic rescue of Δ508 CFTR by Trikafta modulators
Karol Fiedorczuk et al.
SCIENCE (2022)
BCL::Conf: Improved Open-Source Knowledge-Based Conformation Sampling Using the Crystallography Open Database
Jeffrey Mendenhall et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2021)
Elexacaftor is a CFTR potentiator and acts synergistically with ivacaftor during acute and chronic treatment
Ciaran A. Shaughnessy et al.
SCIENTIFIC REPORTS (2021)
A Precision Medicine Approach to Optimize Modulator Therapy for Rare CFTR Folding Mutants
Guido Veit et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Probing biophysical sequence constraints within the transmembrane domains of rhodopsin by deep mutational scanning
Wesley D. Penn et al.
SCIENCE ADVANCES (2020)
Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination
Guido Veit et al.
JCI INSIGHT (2020)
Structural identification of a hotspot on CFTR for potentiation
Fangyu Liu et al.
SCIENCE (2019)
Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
P. G. Middleton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Folding and Misfolding of Human Membrane Proteins in Health and Disease: From Single Molecules to Cellular Proteostasis
Justin T. Marinko et al.
CHEMICAL REVIEWS (2019)
Contribution of Cotranslational Folding Defects to Membrane Protein Homeostasis
Francis J. Roushar et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
A Proteomic Variant Approach (ProVarA) for Personalized Medicine of Inherited and Somatic Disease
Darren M. Hutt et al.
JOURNAL OF MOLECULAR BIOLOGY (2018)
Molecular structure of the ATP-bound, phosphorylated human CFTR
Zhe Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Residual function of cystic fibrosis mutants predicts response to small molecule CFTR modulators
Sangwoo T. Han et al.
JCI INSIGHT (2018)
From the endoplasmic reticulum to the plasma membrane: mechanisms of CFTR folding and trafficking
Carlos M. Farinha et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del
Jennifer L. Taylor-Cousar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
A platform for functional assessment of large variant libraries in mammalian cells
Kenneth A. Matreyek et al.
NUCLEIC ACIDS RESEARCH (2017)
From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations
Gudio Veit et al.
MOLECULAR BIOLOGY OF THE CELL (2016)
Plasmid-based one-pot saturation mutagenesis
Emily E. Wrenbeck et al.
NATURE METHODS (2016)
Automated structure refinement of macromolecular assemblies from cryo-EM maps using Rosetta
Ray Yu-Ruei Wang et al.
ELIFE (2016)
Analysis of cystic fibrosis-associated P67L CFTR illustrates barriers to personalized therapeutics for orphan diseases
Carleen M. Sabusap et al.
JCI INSIGHT (2016)
ΔF508 CFTR interactome remodelling promotes rescue of cystic fibrosis
Sandra Pankow et al.
NATURE (2015)
VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1
Hong Yu Ren et al.
MOLECULAR BIOLOGY OF THE CELL (2013)
Mechanism-based corrector combination restores ΔF508-CFTR folding and function
Tsukasa Okiyoneda et al.
NATURE CHEMICAL BIOLOGY (2013)
Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene
Patrick R. Sosnay et al.
NATURE GENETICS (2013)
High-Resolution Comparative Modeling with RosettaCM
Yifan Song et al.
STRUCTURE (2013)
Cystic Fibrosis Transmembrane Regulator Correctors and Potentiators
Steven M. Rowe et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)
Mechanisms of CFTR folding at the endoplasmic reticulum
Soo Jung Kim et al.
FRONTIERS IN PHARMACOLOGY (2012)
Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
Fredrick Van Goor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The V510D Suppressor Mutation Stabilizes ΔF508-CFTR at the Cell Surface
Tip W. Loo et al.
BIOCHEMISTRY (2010)
Cooperative Assembly and Misfolding of CFTR Domains In Vivo
Kai Du et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
OCTOPUS: improving topology prediction by two-track ANN-based preference scores and an extended topological grammar
Hakan Viklund et al.
BIOINFORMATICS (2008)
Toward high-resolution prediction and design of transmembrane helical protein structures
P. Barth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Multipass membrane protein structure prediction using Rosetta
V Yarov-Yarovoy et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2006)
Small-molecule correctors of defective ΔF508-CFTR cellular processing identified by high-throughput screening
N Pedemonte et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Structure-activity relations of successful pharmacologic chaperones for rescue of naturally occurring and manufactured mutants of the gonadotropin-releasing hormone receptor
JA Janovick et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Green fluorescent protein-based halide indicators with improved chloride and iodide affinities
LJV Galietta et al.
FEBS LETTERS (2001)
分享论文
